Related Experiment Video
Updated: Apr 15, 2026
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
Published on: May 16, 2015
What can you do to protect the newborn brain?
Katherine Louise Shea1, Arvind Palanisamy
1aClinical Fellow in Obstetric Anesthesia bAssistant Professor of Anaesthesia, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts, USA.
Insights
Therapeutic hypothermia is key for neonatal hypoxic-ischemic encephalopathy. Combining it with therapies like melatonin or stem cells shows promise for improved neuroprotection and outcomes in newborns.
Area of Science:
- Neonatal Neurology
- Neuroscience
- Pediatric Critical Care
Background:
- Hypoxic-ischemic brain injury is a major cause of death and disability in newborns.
- Interrupting the excitotoxic-oxidative cascade is crucial for treatment.
- Novel neuroprotection techniques and advances in established therapies are vital.
Purpose of the Study:
- To review novel neuroprotection techniques for neonatal hypoxic-ischemic brain injury.
- To describe the latest advances in established therapeutic methods for neonatal brain injury.
Main Methods:
- Review of current literature on therapeutic hypothermia.
- Analysis of adjuvant therapies combined with hypothermia.
- Evaluation of emerging treatments like stem cell therapy and noble gases.
Main Results:
- Therapeutic hypothermia at 33°C for 72 hours appears optimal for hypoxic-ischemic encephalopathy.
- Antenatal magnesium therapy duration for neuroprotection is still debated, but shorter durations show comparable outcomes.
- Combination therapies (hypothermia + melatonin/erythropoietin) yield better results than hypothermia alone.
- Stem cell therapies demonstrate significant potential in preclinical studies.
Conclusions:
- Optimal temperature and duration for hypothermia in neonatal brain injury management are established.
- Combinatory therapies using adjuncts offer the most promising approach.
- Stem cell therapy and noble gases require further clinical validation.
Purpose Of Review:
Hypoxic-ischemic brain injury is a leading cause of mortality and morbidity in neonates. Treating such injury by interrupting the excitotoxic-oxidative cascade is of immense importance. This review will focus on novel techniques of neuroprotection and describe the latest advances in established therapeutic methods.
Key Findings:
Although the primacy of therapeutic hypothermia in treating hypoxic-ischemic encephalopathy is well established, recent research establishes that the arbitrarily chosen regimen of cooling to 33°C for 72 h may indeed be the most appropriate method. The optimal duration of antenatal magnesium therapy for neuroprotection remains unsettled, though it is reassuring that even 12 h or less of magnesium therapy results in comparable neurological outcomes. Combining adjuvant therapies such as melatonin or erythropoietin with therapeutic hypothermia results in favorable neurological outcomes compared with hypothermia alone. Finally, stem cell-based therapies show considerable potential in preclinical studies.
Summary:
Significant advances have occurred in the management of neonatal brain injury. With establishment of the optimal temperature and duration of hypothermia, combinatory therapies using adjuncts hold the greatest promise. Promising preclinical approaches such as stem cell-based therapy and use of noble gases need to be confirmed with clinical trials.
More Related Videos
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015